Skip to main content
Abbott Laboratories (Pakistan) Limited logo

Abbott Laboratories (Pakistan) Limited — Investor Relations & Filings

Ticker · ABOT ISIN · PK0025701019 LEI · 549300BL6LRIQC5XXV35 PSX Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2026-05-22 Investor Presentation
Country PK Pakistan
Listing PSX ABOT

About Abbott Laboratories (Pakistan) Limited

https://www.pk.abbott/homepage.html

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets a diverse portfolio of healthcare products. Its core activities encompass research-based pharmaceuticals, nutritional products, diagnostic solutions, and diabetes care. The company also provides hospital and consumer products, alongside innovative medical devices and molecular diagnostics, contributing to comprehensive human health solutions.

Recent filings

Filing Released Lang Actions
Presentation of Corporate Briefing Session 2026
Investor Presentation Classification · 90% confidence The document is a slide‐style presentation labeled “Corporate Briefing Session” dated May 25, 2026, containing an overview of core values, history, multi‐year financial snapshots, strategic business segments, awards, future outlook, risks, and a Q&A section. It reads like an investor deck rather than a statutory report or regulatory announcement. There are no indications of a formal annual report filing, proxy statement, or earnings release; instead it is clearly a detailed investor presentation. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-22 English
Corporate Briefing Session 2026
Regulatory Filings Classification · 72% confidence The document is a notice from Abbott Laboratories (Pakistan) Limited announcing a virtual Corporate Briefing Session to discuss the company’s year-ended financial performance, including meeting logistics and access details. It does not contain actual financial results, slide content, or a transcript, nor does it represent a formal report or filing type such as an annual/interim report, audit, or proxy statement. It is an event announcement of a non-regulatory type, falling under miscellaneous regulatory announcements. Therefore, the best match is Regulatory Filings (RNS).
2026-05-22 English
Credit of Final Cash Dividend
Notice of Dividend Amount Classification · 90% confidence The document is a formal announcement addressed to the stock exchange notifying the credit of the final cash dividend of Rs. 40.00 per share (400%) for the year ended December 31, 2025. It provides dividend amount and payment details to shareholders. This fits the definition of a Notice of Dividend Amount (DIV).
2026-05-11 English
Election of Directors
Regulatory Filings
2026-04-30 English
Certified copy of Resolution passed at the 77th Annual General Meeting
Regulatory Filings
2026-04-30 English
Transmission of Quarterly Report for the Period Ended March 31, 2026
Regulatory Filings
2026-04-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.